Posts
Capstone Companies (OTCQB: CAPC) and eBliss Global Issue Joint Statement Regarding Proposed Business Combination Process
**DEERFIELD BEACH, FL /** [**ACCESS Newswire**](https://www.accessnewswire.com/) **/ May 26, 2026 /** Following the recent announcement of a binding Letter of Intent ("LOI") regarding a proposed business combination, Capstone Companies, Inc., a Florida corporation, ("Company") (OTCQB:CAPC) and eBliss Global, Inc. ("eBliss") today issued a joint update regarding the ongoing evaluation process. …
$CTM Castellum Inc - The Penny Stock version of Palantir
$CTM Castellum Inc - a fast growing micro cap based in Virginia USA, $CTM provides intelligence analysis, program management, strategic and mission planning to governments and others, revenue is equal to its market cap of just $60m and it is winning major military and federal contracts, not to mention 25% …
$VNRX – Pulled Back Into a Potential Entry Zone After Friday's Big Move
VolitionRX had a strong run Friday, pushing over $3 on volume more than double its 30-day average. Today it's giving some of that back, down around 7% to $2.90 — but honestly, that's pretty normal price behavior after a spike like that. What's worth noting here: * The **breakout from …
Nikola Motors: $28B market cap. Zero revenue. One rolling truck. Now there's a settlement ongoing
If you were around in those moments of NKLA, here's what $28.8 billion actually represented: * Trucks that weren't functional * A promotional video of a truck rolling downhill under no power * Hydrogen production cost claims that were fabricated * Pre-orders that were largely non-binding * "Proprietary technology" that …
Biotech Short Watchlist Today: IOVA, BDTX, ESPR, SANA, FATE, ALT
I’m watching a few under-$5 biotech names today for possible short setups. My focus is on stocks trading between **$1.50 and $5.00**, with enough volume/movement to actually trade, and preferably names with low or reasonable borrow fees. This is not a “short everything blindly” list. A lot of these names …
RXRX Short Thesis Update: Why I Still Think $2.70 or Lower Is in Play
**Ticker:** RXRX **Company:** Recursion Pharmaceuticals **Current area:** Low-$3s **My bias:** Bearish short-term / tactical short **Primary downside target:** $2.70 **Stretch target:** $2.50–$2.60 **Invalidation:** Reclaim and hold above $3.25–$3.35 # Thesis I’m still looking at RXRX as a tactical short candidate. The setup has not changed much from last week: the …
NREDF Has A 16,078-Hectare BC Copper-Gold Project And A 2026 Geophysics Catalyst Coming
Copper is getting harder to ignore with AI data centers, grid upgrades, defense supply chains, EVs, robotics and electrification all pulling on the same metal. The big copper names are already obvious: FCX, BHP, TECK, HBM. The more interesting penny-stock screen for me is the junior exploration bucket, where one …
The Lounge
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
HYLN — why I think there’s still significant room to run
Hyliion makes the KARNO Power Module, a fuel-agnostic generator that runs on natural gas, hydrogen, diesel, propane, landfill gas, and ammonia — all on the same hardware, no modifications needed. In a distributed power market that’s heating up, it’s a genuinely differentiated product. The news has been stacking up lately. …
$HERB / $LUFFF Herbal Dispatch - Explosive Growth, Record Revenues, Veteran Channel on Fire, International Exports Scaling → Massive Upside in 2026
Hey everyone, Just digging into **Herbal Dispatch (HERB.CN / LUFFF)** — this Canadian cannabis e-comm + export play is firing on all cylinders with serious momentum. Low float microcap with real traction in high-margin medical, edibles, and global markets. **Key Recent Wins (last couple months):** * **Record Financials**: Q4 2025 …